Provided By PR Newswire
Last update: May 22, 2025
Real-World Analysis Shows Statistically Significant Reduction in Severe Bleeding and Transfusion Needs in CABG Patients on the Blood Thinner, Ticagrelor, with CytoSorbents Therapy
Read more at prnewswire.comNASDAQ:CTSO (12/9/2025, 4:30:00 PM)
0.749
+0.03 (+3.51%)
Find more stocks in the Stock Screener


